Skin Line Logistic Pharmaceutical Import Profile — Iraq (DGFT 2022–2026)

Name: Skin Line Logistic Pharmaceutical Import Records from India — 9 Products, $75.9K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Skin Line Logistic — Pharmaceutical Importer Profile (2026) | 9 Products, $75.9K Trade | TransData Nexus

Skin Line Logistic

Pharmaceutical Importer · Iraq · Advanced Oncology Focus · $75.9K Total Trade · DGFT Verified

Skin Line Logistic is a pharmaceutical importer based in Iraq with a total trade value of $75.9K across 9 products in 2 therapeutic categories. Based on 99 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Skin Line Logistic sources from 6 verified Indian suppliers, with Ravi Pharma accounting for 73.1% of imports.

Skin Line Logistic — Import Portfolio & Supplier Network

Skin Line Logistic import network — 9 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Skin Line Logistic?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Ravi Pharma	$606.9K	1,211	73.1%
Shree Rajeshwar Pharma	$76.6K	1,492	9.2%
Seatrack International Tradex Private Limited	$66.9K	163

What Formulations Does Skin Line Logistic Import?

Formulation	Value	Ships
Floricot TAB.fludrocortisone tablets ip20*10 TAB. as per	$33.2K	15
Entavir 0.5 mgentecavir tablets IP 0.5 MG 5*10 TAB as per	$31.3K	5
Mitomycin 40MG INJ.mitomycin injection IP 40MG 1*1 vail as per	$26.6K	5
Nitib cap.ibrutinib capsules 140mg1*30 cap. as per	$25.3K	5
Ketosteril TAB.alpha ketoanalogues of essentiall amino acids	$15.4K	10
Velasof TAB.sofosbuvir 400MG and velpatasvir 100MG	$15.1K	5
Onco bcg INJ.bcg for immunotherapy i.p.1*1 vail as per	$13.8K	5
Penicitin 250MG cap.penicillamine capsules ups 5*10 cap asper	$13.6K	15
Ledifos TAB.ledipasvir and sofosbuvir tablets 1*28 TAB as per	$13.1K	5
Tenvir TAB.tenofovir dioproxil fumaratetablets IP	$11.9K	10
Budez cr budesonide controlled release	$10.8K	5
Medrol TAB.methylprednisolone tablets i.p. 10*10 TAB as per	$10.8K	5
Nab paclitero INJ.paclitaxel protein bound p article / ods / product / item for injectable suspension1*1	$10.5K	5
Thiopton 1GM	$10.1K	2
Velakast TAB.sofosbuvir 400MG and velpatasvir 100MG	$9.3K	15

Skin Line Logistic imports 1,841 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 9 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Ibrutinib	Advanced Oncology	$30.6K	15	3.0%	5
2	Ledipasvir	Antiviral & HIV Medications	$15.1K	10	1.3%	3
3	Pomalidomide	Advanced Oncology	$6.6K	11	0.2%	11
4	Carfilzomib	Advanced Oncology	$5.1K	10	0.4%	8
5	Cabozantinib	Advanced Oncology	$4.7K	21	3.7%	3
6	Regorafenib	Advanced Oncology	$4.6K	7	0.5%	6
7	Axitinib	Advanced Oncology	$3.5K	12	3.8%	3
8	Procarbazine	Advanced Oncology	$3.5K	8	1.3%	5
9	Lomustine	Advanced Oncology	$2.2K	5	2.1%	5

Skin Line Logistic imports 9 pharmaceutical products across 2 categories into Iraq totaling $75.9K.

Skin Line Logistic — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Skin Line Logistic is a pharmaceutical importer based in Iraq, specializing in the procurement of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company plays a pivotal role in enhancing the availability of essential medications within the Iraqi healthcare system. While specific details about its headquarters and parent company are not publicly disclosed, Skin Line Logistic's operations are integral to the distribution of pharmaceutical products across Iraq.

The company's import activities are primarily focused on sourcing medications from India, reflecting a strategic choice to leverage India's robust pharmaceutical manufacturing capabilities. This approach enables Skin Line Logistic to provide a diverse range of therapeutic options to meet the healthcare needs of the Iraqi population.

2Distribution Network

Skin Line Logistic's distribution network encompasses multiple warehouse locations strategically situated to facilitate efficient logistics operations throughout Iraq. These facilities are equipped to handle a wide array of pharmaceutical products, ensuring that medications are stored under optimal conditions to maintain their efficacy and safety. The company's logistics capabilities are designed to support timely and reliable delivery to hospitals, clinics, pharmacies, and other healthcare providers across the country.

While the primary focus is on domestic distribution within Iraq, Skin Line Logistic's established relationships with Indian pharmaceutical manufacturers may provide opportunities for regional expansion. However, specific details regarding geographic coverage beyond Iraq are not publicly available.

3Industry Role

In Iraq's pharmaceutical supply chain, Skin Line Logistic functions as a key importer and distributor of finished pharmaceutical formulations. By sourcing a diverse range of medications from Indian manufacturers, the company ensures the availability of essential drugs that may not be produced locally. This role is crucial in addressing the healthcare needs of the Iraqi population, particularly in therapeutic areas where local production is limited or non-existent.

Skin Line Logistic's operations complement the efforts of local pharmaceutical manufacturers and the Iraqi Ministry of Health, contributing to a more comprehensive and resilient healthcare supply chain. Through its import activities, the company plays a significant part in enhancing the accessibility and affordability of quality medications within Iraq.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Skin Line Logistic

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Skin Line Logistic's sourcing strategy exhibits a high degree of concentration, with a significant portion of its imports originating from a select group of Indian pharmaceutical suppliers. The top five suppliers—Ravi Pharma, Shree Rajeshwar Pharma, Seatrack International Tradex Pvt Ltd, Inthera Pharmamed Biotech Pvt Ltd, and Albasel Export and Import Company—account for a substantial share of the company's total import value. This concentration suggests a strategic partnership approach, potentially leading to favorable terms and streamlined logistics.

However, such dependency on a limited number of suppliers may pose risks related to supply chain disruptions, pricing volatility, and regulatory changes affecting these suppliers. To mitigate these risks, Skin Line Logistic may consider diversifying its supplier base and establishing contingency plans to ensure a continuous and reliable supply of pharmaceutical products.

2Supply Chain Resilience

Skin Line Logistic's supply chain resilience is influenced by its reliance on a concentrated group of Indian pharmaceutical suppliers. While this focus may lead to efficiencies in procurement and logistics, it also exposes the company to potential vulnerabilities. For instance, any disruptions in the operations of key suppliers, such as manufacturing delays, regulatory issues, or geopolitical tensions, could impact the availability of critical medications.

Importing Pharmaceuticals into Iraq — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Iraq

1Regulatory Authority & Framework

The Iraqi Ministry of Health (MOH) is the primary regulatory authority overseeing the pharmaceutical sector in Iraq. Through the Iraq Drug Regulatory Authority (IDRA), the MOH is responsible for controlling marketing authorization, pricing oversight, pharmacovigilance, inspections, import permissions, and promotion rules. Quality and standards interact with the Central Organization for Standardization and Quality Control (COSQC), which operates under the Ministry of Planning. Additionally, localization incentives are influenced by the Ministry of Industry & Minerals.

Pharmaceutical products, including biologics and biosimilars, require IDRA approval based on safety, efficacy, and quality, with evidence of Good Manufacturing Practice (GMP) compliance. Marketing authorizations are typically time-limited (commonly five years) and renewable with updated data. Generics follow an abbreviated, bioequivalence-driven route, while biologics and biosimilars require comparability packages. Promotion is tightly controlled, with strict rules on healthcare professional interactions.

2Import Licensing & GMP

Import licensing in Iraq is governed by the Ministry of Health, which implements regulations similar to many emerging markets. Pharmaceutical companies and products must be registered with the Technical Affairs Directorate. Market authorization holders are responsible for product quality and recalls, with the regulator's ability to enforce quality pharmacovigilance extremely limited at present. However, the Ministry of Health mandates the right to carry out inspections to ensure Good Manufacturing Practice (GMP) compliance if deemed necessary.

Skin Line Logistic — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Skin Line Logistic's product strategy focuses on importing a diverse range of pharmaceutical formulations, with a significant emphasis on advanced oncology medications and antiviral & HIV treatments. This focus aligns with the therapeutic needs of the Iraqi population, addressing critical health challenges such as cancer and infectious diseases. The company's portfolio concentration, with the top five products accounting for 81.8% of total imports, indicates a strategic approach to sourcing high-demand medications.

The market demand for these therapeutic areas is driven by the prevalence of related health conditions in Iraq and the limited availability of such specialized treatments from local manufacturers. By importing these products, Skin Line Logistic plays a crucial role in enhancing the accessibility and affordability of essential medications, thereby improving patient outcomes and supporting the overall healthcare infrastructure in the country.

2Sourcing Profile

Skin Line Logistic's sourcing strategy is characterized by a focus on finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, sourced from Indian manufacturers. This approach allows the company to offer a wide array of therapeutic options to meet the diverse healthcare needs of the Iraqi population. The selection of Indian suppliers is likely influenced by India's established reputation for producing high-quality, cost-effective pharmaceutical products.

Frequently Asked Questions — Skin Line Logistic

What products does Skin Line Logistic import from India?

Skin Line Logistic imports 9 pharmaceutical products across 2 categories. Top imports: Ibrutinib ($30.6K), Ledipasvir ($15.1K), Pomalidomide ($6.6K), Carfilzomib ($5.1K), Cabozantinib ($4.7K).

Who supplies pharmaceuticals to Skin Line Logistic from India?

Skin Line Logistic sources from 6 verified Indian suppliers. The primary supplier is Ravi Pharma (73.1% of imports, $606.9K).

What is Skin Line Logistic's total pharmaceutical import value?

Skin Line Logistic's total pharmaceutical import value from India is $75.9K, based on 99 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Skin Line Logistic focus on?

Skin Line Logistic imports across 2 categories. The largest: Advanced Oncology (80.1%), Antiviral & HIV Medications (19.9%).

Get Full Skin Line Logistic Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.